You are viewing: Rest Of Asia Pacific Structural Heart Devices Market analysis

The Rest Of Asia Pacific Structural Heart Devices Market was valued at $169.8 Million in 2024 and projected to reach to $274.9 Million by 2029, representing a compound annual growth rate of 10.1%. Rest Of Asia Pacific represents a high-growth opportunity within the broader Asia Pacific structural heart devices landscape.

Rest Of Asia Pacific Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Asia Pacific Structural Heart Devices Market Trends and Insights

  • Rest Of Asia Pacific represents a high-growth opportunity within the broader Asia Pacific region, driven by increasing prevalence of structural heart conditions, aging populations, and rising healthcare expenditure across emerging economies.
  • The region's market growth outpaces the global average, reflecting accelerating adoption of minimally invasive procedures and improved access to advanced cardiac interventions. Rest Of Asia Pacific's structural heart devices sector is characterized by growing demand for transcatheter aortic valve replacement (TAVR), mitral valve repair systems, and left atrial appendage (LAA) closure devices.
  • Between 2024 and 2029, Rest Of Asia Pacific will benefit from expanding healthcare infrastructure, increasing physician training programs, and regulatory approvals facilitating market entry.
  • The region's 10.1% compound annual growth rate underscores strong market fundamentals and sustained investment in cardiovascular care capabilities..

Key Market Statistics

  • CAGR (2024-2029) 10.1% CAGR
  • Market Size, 2024 ~USD 169.8 Million
  • Forecast, 2029 ~USD 274.9 Million
  • Country Rest Of Asia Pacific

Rest Of Asia Pacific Structural Heart Devices Market Overview

Rapid Market Expansion :

Rest Of Asia Pacific structural heart devices market is growing at 10.1% CAGR, outpacing the global average of 9.5%, reflecting strong regional demand and investment in cardiovascular care infrastructure.

Aging Population Dynamics :

Demographic shifts across Rest Of Asia Pacific countries are driving increased prevalence of structural heart conditions, creating sustained demand for innovative device solutions and interventional procedures.

Healthcare Expenditure Growth :

Rising healthcare spending and government initiatives to improve cardiac care access in Rest Of Asia Pacific nations are accelerating adoption of advanced structural heart devices and minimally invasive treatments.

Market Valuation Trajectory :

Market size is projected to grow from USD 169.8 million in 2024 to USD 274.9 million by 2029, representing a 62% increase and establishing Rest Of Asia Pacific as a critical growth market for device manufacturers.

Rest Of Asia Pacific Structural Heart Devices Market Dynamics

  • The region's expanding middle class, coupled with increasing awareness of cardiovascular health and improved diagnostic capabilities, is driving robust demand for structural heart interventions.
  • Government healthcare reforms and rising private sector investment in cardiac centers are enhancing procedural volumes and device adoption rates. Looking ahead, Rest Of Asia Pacific is poised for accelerated growth through 2029, supported by favorable demographic trends, economic development, and technological advancement.
  • Key drivers include the aging population requiring valve replacements and repair, growing prevalence of atrial fibrillation, and expanding reimbursement frameworks.
  • Strategic partnerships between global device manufacturers and regional healthcare providers will further penetrate emerging markets within this dynamic region..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Rest Of Asia Pacific's structural heart devices market will grow from USD 169.8M (2024) to USD 274.9M (2029) at a 10.1% CAGR, outpacing global growth.
    • Rest Of Asia Pacific is experiencing accelerating adoption of minimally invasive structural heart interventions driven by aging demographics and rising healthcare investment.
    • Rest Of Asia Pacific's market expansion is supported by regulatory approvals, physician training initiatives, and improved reimbursement frameworks across emerging economies.
    • Rest Of Asia Pacific represents a high-priority growth region for structural heart device manufacturers seeking to capitalize on unmet clinical needs and expanding procedural volumes.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    Rest Of Asia Pacific Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    Target Audience

    • Medical Device Manufacturers : Need Rest Of Asia Pacific-specific market data to guide product launches, pricing strategies, and commercial investments in this high-growth region with distinct regulatory and reimbursement environments.
    • Healthcare Investment Firms : Require detailed regional market analysis to evaluate investment opportunities in Rest Of Asia Pacific cardiac care infrastructure, device distribution networks, and healthcare service providers.
    • Hospital & Clinic Operators : Seek market intelligence on structural heart device demand, adoption trends, and reimbursement patterns in Rest Of Asia Pacific to optimize procurement and service line development.
    • Market Research & Strategy Consultants : Need granular Rest Of Asia Pacific market data and forecasts to support client advisory work, competitive analysis, and strategic planning in the structural heart devices sector.
    • Regulatory & Policy Advisors : Require region-specific market insights to understand healthcare trends, device adoption patterns, and policy implications affecting structural heart care delivery in Rest Of Asia Pacific.

    Reasons to Buy this Report

    • Regional Growth Validation : Confirm that Rest Of Asia Pacific outperforms global CAGR at 10.1% vs 9.5%, validating this region as a priority market for expansion and resource allocation decisions.
    • Market Sizing & Forecasting : Access precise valuation data (USD 169.8M in 2024 growing to USD 274.9M by 2029) to support financial projections, investment cases, and competitive positioning strategies specific to Rest Of Asia Pacific.
    • Demographic & Healthcare Insights : Understand aging population trends and rising healthcare expenditure patterns unique to Rest Of Asia Pacific countries, enabling targeted product development and market entry strategies.
    • Competitive Opportunity Assessment : Identify market gaps and growth drivers specific to Rest Of Asia Pacific to benchmark against competitors and prioritize commercial initiatives in this high-potential region.
    • Strategic Planning Support : Leverage region-specific market intelligence to inform partnership strategies, distribution channel optimization, and regulatory pathway planning for Rest Of Asia Pacific expansion.

    Frequently asked questions

    What is the market size of structural heart devices in Rest Of Asia Pacific in 2024?

    Rest Of Asia Pacific's structural heart devices market is valued at USD 169.8 million in 2024, representing significant growth potential within the Asia Pacific region.

    What is the projected market size for Rest Of Asia Pacific by 2029?

    Rest Of Asia Pacific's structural heart devices market is forecast to reach USD 274.9 million by 2029, reflecting a 10.1% compound annual growth rate.

    What is driving growth in Rest Of Asia Pacific's structural heart devices market?

    Rest Of Asia Pacific's market growth is driven by aging populations, increasing structural heart disease prevalence, expanding healthcare infrastructure, regulatory approvals, and rising adoption of minimally invasive procedures.

    How does Rest Of Asia Pacific's growth rate compare to global trends?

    Rest Of Asia Pacific's 10.1% CAGR exceeds the global structural heart devices market CAGR of 9.5%, positioning the region as a high-growth opportunity.

    Which device types are most in demand in Rest Of Asia Pacific?

    Rest Of Asia Pacific shows strong demand for transcatheter aortic valve replacement (TAVR) systems, mitral valve repair devices, and left atrial appendage (LAA) closure solutions.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status